Novo Nordisk A/S, the largest producer of diabetes products, reported a 20% increase in sales in the third quarter to DKK 19.85 billion (€2.66 billion). Net profit rose by 35% to DKK 5.67 billion, giving a net profit margin of 28.6%. ---Subscribe to MedNous to access this article--- Company News
